, Tracking Stock Market Picks
Enter Symbol:

down 77.52 %

ATHENAHEALTH INC (ATHN) downgraded to Sell with price target $22 by Brean Murray

Posted on: Thursday,  Aug 19, 2010  8:25 AM ET by Brean Murray

Brean Murray rated Sell ATHENAHEALTH INC (NASDAQ: ATHN) on 08/19/2010, when the stock price was $30.24. Since
then, ATHENAHEALTH INC has gained 344.97% as of 11/17/2015's recent price of $134.56.
If you would have followed this Brean Murray's recommendation on ATHN, you would have lost 77.52% of your investment in 1916 days.

athenahealth, Inc. (athena) is a provider of Internet-based business services for physician practices. The Company's service offerings are based on four integrated components: its Internet-based software, its continually updated database of payer reimbursement process rules, its back-office service operations that perform administrative aspects of billing and clinical data management for physician practices, and its automated and live patient communication services. The Company?s principal offering, athenaCollector, automates and manages billing-related functions for physician practices and includes a medical practice management platform. The Company has also developed a service offering, athenaClinicals that automates and manages medical record-related functions for physician practices and includes an electronic medical record (EMR) platform. In October 2009, the Company completed the acquisition of Anodyne Health Partners, Inc.

Our equity research department is focused on fundamental analysis across the universe of over 200 small/mid cap stocks in our five target sectors. We are committed to providing proprietary action-oriented research to our institutional clients. Small cap growth focus. Our primary area of concentration is growth stocks with market capitalization of $200 million to $5 billion. Global perspective. We are covering U.S. listed stocks for companies domiciled in the U.S., China, Europe and Latin America, with our biggest concentration in the US and China. We were one of the first banks to aggressively expand our research to China and we believe we created one of the premier research franchises in small cap, U.S. listed Chinese companies to complement our strong domestic coverage. Disciplined stock selection. Our research analysts are focused on performing extensive bottoms up due diligence on companies under our coverage by leveraging their industry and management contacts. By combining our bottoms up work with our sector views we seek to generate a consistent flow of high conviction ideas for our clients. Diversified coverage. Our areas of expertise include technology, consumer, healthcare, resources and China small cap. We provide our clients with company-specific as well as sector-specific research across our target sectors.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/19/2010 8:25 AM Sell
30.24 22.00
as of 12/31/2010
1 Week down  -6.01 %
1 Month down  -7.02 %
3 Months down  -32.91 %
1 YTD down  -45.13 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/14/2009 8:25 AM Hold
12/4/2009 8:25 AM Buy
46.89 48.00
8/6/2009 3:25 PM Buy
36.41 40.00
6/9/2009 8:25 AM Buy
31.68 36.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy